Storied enterprise agency Y Combinator has terminated its affiliation with Medobed, an Indian startup that guarantees medication supply, in 10 minutes after discovering “irregularities” on the agency, a number of individuals conversant in the matter informed TechCrunch.
A YC accomplice has additionally warned many buyers in current days about its discovery of “irregularities” on the agency, and cautioned them to not interact with the startup, in keeping with two individuals conversant in the matter, and a duplicate of the e-mail seen by TechCrunch.
Within the e-mail, the YC accomplice stated the enterprise agency “found irregularities that broke our ethics coverage.”
“You probably have something excellent with this firm,” the YC accomplice wrote, “our advice is to disengage utterly with the corporate.” He added, “they aren’t longer a part of YC, gained’t do YC demo day, and, so far as we all know, haven’t raised any cash as a part of this course of.”
YC and founders of Medobed, which was initially chosen in S23 batch, didn’t reply to a request for touch upon August 29.
An investor who had been individually pitched by Medobed stated one of many founder’s claims sounded suspicious. The founder stored altering story about his training background and the metrics in regards to the agency’s progress appeared off, stated the investor, who requested anonymity talking.
Extra to observe.